Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis

View source ↗

Summary

Clinical trial update for rezafungin evaluating peritoneal diffusion to treat intra-abdominal candidiasis; recruiting at a French center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rezafungin (rezafungin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Intra-Abdominal Infection, Candida | Status: RECRUITING